5 0 0 0 OA 化粧品による有害事象と化粧品メーカー対応の歴史~黒皮症から白斑まで~
- 著者
- 高野 勝弘
- 出版者
- 日本香粧品学会
- 雑誌
- 日本香粧品学会誌 (ISSN:18802532)
- 巻号頁・発行日
- vol.39, no.1, pp.17-22, 2015-03-31 (Released:2016-05-11)
- 参考文献数
- 22
There are various types of side effects caused by cosmetics; mostly they are believed to be not serious. Further, there are not a few cases at present that it is difficult to identify which ingredients in cosmetic products caused; even it was certainly caused by cosmetics which had been used. It herewith refers the actual cases which were implemented some measures by MHLW (Ministry of Health, Labour and Welfare of Japan) under the jurisdiction of Pharmaceutical Affairs Law or JCIA (Japan Cosmetic Industry Association) as a representative of cosmetic industries, taking into account the cases must be caused by cosmetics (including quasi-drugs such as medicated cosmetics). It also covers the background and history of cosmetic regulation under the Pharmaceutical Affairs Law in considering the safety of cosmetics.
2 0 0 0 OA 抗血小板療法のモニタリングと薬剤抵抗性
- 著者
- 高野 勝弘 尾崎 由基男
- 出版者
- 一般社団法人 日本脳卒中学会
- 雑誌
- 脳卒中 (ISSN:09120726)
- 巻号頁・発行日
- vol.30, no.6, pp.953-959, 2008 (Released:2009-01-13)
- 参考文献数
- 10
- 被引用文献数
- 5 1
To monitor the effectiveness of anti-platelet therapy should be important since anti-platelet drug "resistance" or non-compliance can be evaluated clearly by it. However, the anti-platelet therapy monitoring is not widely practiced, probably due to poorly-standardized platelet function test. Among the anti-platelet drug resistance, aspirin resistance is one of the most important topics in clinical thrombosis and hemostasis field. Also, clopidogrel resistance recently became a big issue. Monitoring of anti-platelet therapy is needed for further understanding of these anti-platelet drug resistances.